Vanda Pharmaceuticals
VNDA
#7728
Rank
A$0.51 B
Marketcap
A$8.68
Share price
1.16%
Change (1 day)
20.97%
Change (1 year)

Vanda Pharmaceuticals (VNDA) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$0.19 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's total liabilities are A$0.19 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Vanda Pharmaceuticals - Total liabilities on balance sheet (from 2005 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$0.18 B24.48%
2023-12-31A$0.15 B-3.4%
2022-12-31A$0.15 B28.34%
2021-12-31A$0.12 B17.53%
2020-12-31A$0.10 B0.29%
2019-12-31A$0.10 B29.18%
2018-12-31A$80.49 M-15.12%
2017-12-31A$94.83 M-13.52%
2016-12-31A$0.10 B-0.17%
2015-12-31A$0.10 B725.75%
2014-12-31A$13.3 M-88.04%
2013-12-31A$0.11 B-7.92%
2012-12-31A$0.12 B-16.95%
2011-12-31A$0.14 B-15.75%
2010-12-31A$0.17 B-23.48%
2009-12-31A$0.22 B3967.48%
2008-12-31A$5.54 M-63.07%
2007-12-31A$15.02 M24.59%
2006-12-31A$12.05 M73.37%
2005-12-31A$6.95 M197.52%
2004-12-31A$2.33 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
A$167.42 B 86,969.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$91.63 B 47,553.93%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$164.53 B 85,466.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$122.28 B 63,493.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$110.47 B 57,350.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$101.78 B 52,831.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
A$0.37 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA